Related references
Note: Only part of the references are listed.The role of cell-free circulating DNA in the diagnosis and prognosis of prostate cancer
Joerg Ellinger et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2011)
Differential Methylation of Cell-Free Circulating DNA Among Patients With Pancreatic Cancer Versus Chronic Pancreatitis
Thomas Liggett et al.
CANCER (2010)
Mitochondrial DNA copy number and lung cancer risk in a prospective cohort study
H. Dean Hosgood et al.
CARCINOGENESIS (2010)
Is the role of circulating DNA as a biomarker of cancer being prematurely overrated?
Maniesh van der Vaart et al.
CLINICAL BIOCHEMISTRY (2010)
What determines individuals' preferences for colorectal cancer screening programmes? A discrete choice experiment
L. van Dam et al.
EUROPEAN JOURNAL OF CANCER (2010)
Prospective Clinical Validation of an Assay for Methylated SEPT9 DNA in Human Plasma as a Colorectal Cancer Screening Tool in Average Risk Men and Women ≥50 Years
Timothy R. Church et al.
GASTROENTEROLOGY (2010)
Circulating free DNA, p53 antibody and mutations of KRAS gene in endometrial cancer
Bozena Dobrzycka et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Circulating DNA is a non-invasive prognostic factor for survival in non-small cell lung cancer
Miep A. van der Drift et al.
LUNG CANCER (2010)
Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts
Alain R. Thierry et al.
NUCLEIC ACIDS RESEARCH (2010)
Usefulness of cell-free plasma DNA, procalcitonin and C-reactive protein as markers of infection in febrile patients
Vanessa Garcia Moreira et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2010)
Circulating mitochondrial DNA in the serum of patients with testicular germ cell cancer as a novel noninvasive diagnostic biomarker
Joerg Ellinger et al.
BJU INTERNATIONAL (2009)
Decreased mitochondrial DNA content in blood samples of patients with stage I breast cancer
Peng Xia et al.
BMC CANCER (2009)
The size of the prize for earlier diagnosis of cancer in England
M. A. Richards
BRITISH JOURNAL OF CANCER (2009)
Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer
F. Parente et al.
BRITISH JOURNAL OF SURGERY (2009)
Optimizing the yield and utility of circulating cell-free DNA from plasma and serum
Xiaoyan Xue et al.
CLINICA CHIMICA ACTA (2009)
Multimarker Circulating DNA Assay for Assessing Blood of Prostate Cancer Patients
Eiji Sunami et al.
CLINICAL CHEMISTRY (2009)
Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal Cancer
Theo deVos et al.
CLINICAL CHEMISTRY (2009)
Comparison of Circulating Plasma DNA Levels between Lung Cancer Patients and Healthy Controls
Kyong-Ah Yoon et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2009)
Free circulating DNA based colorectal cancer screening from peripheral blood: the possibility of the methylated septin 9 gene marker
Kinga Tóth et al.
ORVOSI HETILAP (2009)
Quantification of LINE1 in circulating DNA as a molecular biomarker of breast cancer
Eiji Sunami et al.
CIRCULATING NUCLEIC ACIDS IN PLASMA AND SERUM V (2008)
Circulating DNA in the blood of gastric cancer patients
Elena V. Kolesnikova et al.
CIRCULATING NUCLEIC ACIDS IN PLASMA AND SERUM V (2008)
The origin of elevated levels of circulating DNA in blood plasma of premature neonates
N. O. Tnaeva et al.
CIRCULATING NUCLEIC ACIDS IN PLASMA AND SERUM V (2008)
Isolation and extraction of circulating tumor DNA from patients with small cell lung cancer
Ruth E. Board et al.
CIRCULATING NUCLEIC ACIDS IN PLASMA AND SERUM V (2008)
An improved method for the isolation of free-circulating plasma DNA and cell-free DNA from other body fluids
Christoph Kirsch et al.
CIRCULATING NUCLEIC ACIDS IN PLASMA AND SERUM V (2008)
被撤回的出版物: Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancer (Retracted article. See vol. 19, pg. 508, 2013)
Eddy S. Leman et al.
CLINICAL CANCER RESEARCH (2008)
Identification of loss of heterozygosity on circulating free DNA in peripheral blood of prostate cancer patients:: Potential and technical improvements
Imke Mueller et al.
CLINICAL CHEMISTRY (2008)
Quantification of free circulating tumor DNA as a diagnostic marker for breast cancer
Raquel Catarino et al.
DNA AND CELL BIOLOGY (2008)
Concentration and microsatellite status of plasma DNA for monitoring patients with renal carcinoma
Roberto A. Perego et al.
EUROPEAN JOURNAL OF CANCER (2008)
Noncancerous PTGS2 DNA fragments of apoptotic origin in sera of prostate cancer patients qualify as diagnostic and prognostic indicators
Joerg Ellinger et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Circulating mutant DNA to assess tumor dynamics
Frank Diehl et al.
NATURE MEDICINE (2008)
Neutrophil-derived circulating free DNA (cf-DNA/NETs):: A potential prognostic marker for posttraumatic development of inflammatory second hit and sepsis
Stefan Margraf et al.
SHOCK (2008)
Low copy number and low oxidative damage of mitochondrial DNA are associated with tumor progression in lung cancer tissues after neoadjuvant chemotherapy
C.-S. Lin et al.
Interactive Cardiovascular and Thoracic Surgery (2008)
Free circulating DNA as possible tumour marker in colorectal cancer
L. Boni et al.
SURGICAL ONCOLOGY-OXFORD (2007)
Serial assessment of human tumor burdens in mice by the analysis of circulating DNA
Carlo Rago et al.
CANCER RESEARCH (2007)
Increased concentrations of antibody-bound circulatory cell-free DNA in rheumatoid arthritis
Xiao-Yan Zhong et al.
CLINICAL CHEMISTRY (2007)
Laboratory diagnosis of cytomegalovirus infection and disease in immunocompromised patients
W. Lawrence Drew
CURRENT OPINION IN INFECTIOUS DISEASES (2007)
Free DNA and carcinoembryonic antigen serum levels: An important combination for diagnosis of colorectal cancer
Emanuela Flamini et al.
CLINICAL CANCER RESEARCH (2006)
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer
Gershon Y. Locker et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Screening for colorectal cancer in Uruguay with an immunochemical faecal occult blood test
Eduardo Fenocchi et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2006)
Prediction of breast tumor progression by integrity of free circulating DNA in serum
Naoyuki Umetani et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: Direct quantitative PCR for ALU repeats
Naoyuyi Umetani et al.
CLINICAL CHEMISTRY (2006)
Detection and quantification of mutations in the plasma of patients with colorectal tumors
F Diehl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programmes: a cluster randomized controlled trial
A Federici et al.
JOURNAL OF MEDICAL SCREENING (2005)
Cancer genes and the pathways they control
B Vogelstein et al.
NATURE MEDICINE (2004)
Preferential isolation of fragmented DNA enhances the detection of circulating mutated k-ras DNA
MJ Wang et al.
CLINICAL CHEMISTRY (2004)
Plasma mitochondrial DNA concentrations after trauma
NYL Lam et al.
CLINICAL CHEMISTRY (2004)
Time course of early and late changes in plasma DNA in trauma patients
NYL Lam et al.
CLINICAL CHEMISTRY (2003)
Changes in concentration of DNA in serum and plasma during storage of blood samples
M Jung et al.
CLINICAL CHEMISTRY (2003)
Circulating DNA in plasma and serum: Biology, preanalytical issues and diagnostic applications
YYN Lui et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2002)
About the possible origin and mechanism of circulating DNA - Apoptosis and active DNA release
M Stroun et al.
CLINICA CHIMICA ACTA (2001)
Screening with faecal occult blood test (FOBT) for colorectal cancer: assessment of two methods that attempt to improve compliance
L Ore et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2001)
Quantitation of genomic DNA in plasma and serum samples: higher concentrations of genomic DNA found in serum than in plasma
TH Lee et al.
TRANSFUSION (2001)
Share Paper
